U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277933) titled 'Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects' on Nov. 28.
Brief Summary: This study is a randomized, double-blind, placebo-controlled, parallel-group clinical trial. To preliminarily evaluate the safety and efficacy of KHN702 tablets in moderate to severe post-operative pain patients.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Postoperative Pain
Intervention:
DRUG: KHN702
KHN702 tablet for oral administration
DRUG: KHN702 placebo
KHN702 placebo tablet for oral administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chengdu Kanghong Pharmaceutical G...